---
title: "JAFRON: The extracorporeal circulation blood pathway of the blood purification device has obtained EU MDR certification"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245067489.md"
description: "According to the Zhitong Finance APP, JAFRON announced that the company recently received a notification from the EU announcement agency, stating that the company's blood purification device's extracorporeal circulation blood path has obtained the EU MDR certification issued in accordance with the EU Medical Devices Regulation (EU) 2017/745 (referred to as \"MDR\"), allowing it to be sold in EU countries and other countries that recognize EU CE certification"
datetime: "2025-06-18T10:20:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245067489.md)
  - [en](https://longbridge.com/en/news/245067489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245067489.md)
generator: "portal-rs"
---

# JAFRON: The extracorporeal circulation blood pathway of the blood purification device has obtained EU MDR certification

According to the Zhitong Finance APP, JAFRON (300529.SZ) announced that the company recently received a notification from the EU announcement agency, stating that the company's blood purification device's extracorporeal circulation blood pathway has obtained the EU MDR certification issued in accordance with the EU Medical Devices Regulation (EU) 2017/745 (referred to as "MDR"), allowing it to be sold in EU countries and other countries that recognize EU CE certification

### Related Stocks

- [300529.CN](https://longbridge.com/en/quote/300529.CN.md)

## Related News & Research

- [Jiangsu Yuyue Medical Equipment & Supply: Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply](https://longbridge.com/en/news/296602713.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [Kelun-Biotech: Buy Rating Reaffirmed as Strong sac-TMT Momentum Drives Target Price Increase from HK$507.11 to HK$642.29](https://longbridge.com/en/news/296393818.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**